• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of the protonation of isophosphoramide mustard and phosphoramide mustard.

作者信息

Millis K K, Colvin M E, Shulman-Roskes E M, Ludeman S M, Colvin O M, Gamcsik M P

机构信息

Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

J Med Chem. 1995 Jun 9;38(12):2166-75. doi: 10.1021/jm00012a017.

DOI:10.1021/jm00012a017
PMID:7783148
Abstract

The alkylating agent isophosphoramide mustard (IPM) spontaneously forms a relatively stable aziridine derivative which can be directly observed using NMR spectroscopy. The protonations of IMP and its aziridine were probed using 1H, 31P, 15N, and 17O NMR spectroscopy. The positions of the 31P, 15N, and 17O resonances of IPM between pH 2 and 10 each exhibit a single monobasic titration curve with the same pKa of 4.31 +/- 0.02. On the basis of a comparison with other compounds and our earlier work with phosphoramide mustard, the NMR results for IPM indicate that protonation occurs at nitrogen and not oxygen. Over this same pH range, each of the 1H, 31P, and 15N resonances of IPM-aziridine also show a single monobasic titration with a pKa of 5.30 +/- 0.09. The magnitude of the change in chemical shifts suggests that the protonation of the IPM-aziridine occurs at the ring nitrogen. Theoretical gas-phase calculations of PM, IPM, and IPM-aziridine suggest O-protonation to be more likely; however, aqueous phase calculations predict the N-protonated forms to be most stable. Furthermore, for PM and IPM-aziridine, which contain nonequivalent nitrogens, the theoretical calculations and experimental data both agree as to which nitrogen undergoes protonation. These results suggest that the IMP-aziridine remains unprotonated under physiological conditions and may, in part, explain the lower alkylating activity of IPM as compared to PM.

摘要

相似文献

1
Comparison of the protonation of isophosphoramide mustard and phosphoramide mustard.
J Med Chem. 1995 Jun 9;38(12):2166-75. doi: 10.1021/jm00012a017.
2
Protonation of phosphoramide mustard and other phosphoramides.磷酰胺氮芥及其他磷酰胺的质子化作用。
J Med Chem. 1993 Nov 12;36(23):3636-45. doi: 10.1021/jm00075a019.
3
31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard.
J Med Chem. 1989 Aug;32(8):1768-73. doi: 10.1021/jm00128a018.
4
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.
Chem Res Toxicol. 2004 Sep;17(9):1217-26. doi: 10.1021/tx030051k.
5
Identification of new aqueous chemical degradation products of isophosphoramide mustard.
J Pharm Biomed Anal. 2001 Jun;25(3-4):669-78. doi: 10.1016/s0731-7085(00)00582-3.
6
Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.细胞抑制药物异环磷酰胺及其N-去氯乙基代谢物在酸性水溶液中的化学稳定性和归宿
J Med Chem. 1999 Jul 15;42(14):2542-60. doi: 10.1021/jm980587g.
7
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.中国仓鼠卵巢细胞中异环磷酰胺诱导毒性的选择性增强。
Cancer Chemother Pharmacol. 2003 Oct;52(4):291-302. doi: 10.1007/s00280-003-0672-2. Epub 2003 Jul 4.
8
DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide.
Cancer Chemother Pharmacol. 2000;45(1):59-62. doi: 10.1007/pl00006744.
9
Preclinical pharmacokinetics and stability of isophosphoramide mustard.异环磷酰胺氮芥的临床前药代动力学与稳定性
Cancer Chemother Pharmacol. 1994;33(5):391-8. doi: 10.1007/BF00686268.
10
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.异环磷酰胺氮芥,异环磷酰胺的一种代谢产物,其对鼠肿瘤的活性与环磷酰胺相当。
Br J Cancer. 1983 Jan;47(1):15-26. doi: 10.1038/bjc.1983.2.

引用本文的文献

1
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.用缺氧激活前药 CP-506 选择性靶向肿瘤缺氧。
Mol Cancer Ther. 2021 Dec;20(12):2372-2383. doi: 10.1158/1535-7163.MCT-21-0406. Epub 2021 Oct 8.
2
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials.缺氧激活前体药物与(缺乏)临床进展:III期临床试验中基于缺氧生物标志物进行患者选择的必要性。
Clin Transl Radiat Oncol. 2019 Jan 18;15:62-69. doi: 10.1016/j.ctro.2019.01.005. eCollection 2019 Feb.
3
Some physicochemical properties of the antitumor drug thiotepa and its metabolite tepa as obtained by density functional theory (DFT) calculations.
通过密度泛函理论(DFT)计算得到的抗肿瘤药物噻替哌及其代谢物替派的一些物理化学性质。
J Mol Model. 2010 Aug;16(8):1383-90. doi: 10.1007/s00894-010-0658-z. Epub 2010 Feb 14.
4
Design and synthesis of phosphotyrosine peptidomimetic prodrugs.磷酸酪氨酸拟肽前药的设计与合成。
J Med Chem. 2006 Jun 1;49(11):3368-76. doi: 10.1021/jm060142p.